TY - JOUR
AU - X. Xiong
AU - S. Braun
AU - M. Stitzer
AU - H. Luderer
AU - G. Shafai
AU - B. Hare
AU - M. Stevenson
AU - Y. Maricich
A1 - 
AD - Medical Affairs, Pear Therapeutics (US), Boston, Massachusetts, USA.; Behavioral Pharmacology Research Unit, Friends Research Institute, Baltimore, Maryland, USA.
AN - 36264211
BT - Am J Addict
C5 - Opioids & Substance Use
CP - 1
DA - Jan
DO - 10.1111/ajad.13346
DP - NLM
ET - 20221020
IS - 1
JF - Am J Addict
LA - eng
PY - 2023
SN - 1055-0496 (Print); 1055-0496
SP - 24
EP - 31+
ST - Evaluation of real-world outcomes associated with use of a prescription digital therapeutic to treat substance use disorders
T1 - Evaluation of real-world outcomes associated with use of a prescription digital therapeutic to treat substance use disorders
T2 - Am J Addict
TI - Evaluation of real-world outcomes associated with use of a prescription digital therapeutic to treat substance use disorders
U1 - Opioids & Substance Use
U3 - 10.1111/ajad.13346
VL - 32
VO - 1055-0496 (Print); 1055-0496
Y1 - 2023
ER -